Relief Therapeutics Holding AG (RLFTF)

[tcm55]

Through the info gathered from Clinical Trials it seems this new wrinkle of different affects for Vip-1 and VIP2. Pha* still has a strong pipeline for PAH, another serious result of COVID. Repair of arterial issues is barely secondary to the Lung issues which happen earlier in the infection's path. A patient has to lIVE long enough to start working at the other resulting problems.

A message stated that the need to progress past long Trials would result in a much higher Death count, MANY more. These Drugs, in the process of completing their 2b Trials, seem to have shown very important and impressive result, Survival thru positive affects on the breathing mechanism. The FIRST step toward any healing, IMO.

Delaying/limiting access to a few patients thru continued Trials for more proof that these Drugs are safe and effective, is where things are now.

The FDA took the political path of authorizing Rem with it's meager positive affects. OK, done. Next...

The Record - World wide increases in infections proves that this illness is NOT just "going away" and has NOT been 'conquered". Actual Biggie Pharmas will NOT accept false or misleading claims for their antibodies or Vaccines or treatments etc until researched enough to quell the questions of these NEW drugs' SAFETY, at the least. "Cure" is a Big word in COVID with many levels just as is a 'Cure" claim for Cancers.

There comes a time in many things that simple and safe, with actual adequate / superior results proven thru accepted DATA in an accepted setting, 2b Clinical Trials should be enough. Political pressure or the lack of political support or a prolonged path for Patients should not result in More Deaths due to FDA questionable delays or priorities...JMHFO...GLTA...